{"id":"https://openalex.org/W4361811274","doi":"https://doi.org/10.1158/0008-5472.22403628","title":"Supplementary Figures 1 - 10, Tables 1 - 4 from Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition","display_name":"Supplementary Figures 1 - 10, Tables 1 - 4 from Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361811274","doi":"https://doi.org/10.1158/0008-5472.22403628"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22403628","doi":"https://doi.org/10.1158/0008-5472.22403628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22403628","pdf_url":"https://aacr.figshare.com/ndownloader/files/39849438","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/ndownloader/files/39849438","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048967405","display_name":"Naoya Mimura","orcid":"https://orcid.org/0000-0002-1717-9428","observed_orcids":["https://orcid.org/0000-0002-1717-9428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoya Mimura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966810","display_name":"Toshiyasu Shimomura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiyasu Shimomura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039444594","display_name":"Rikio Suzuki","orcid":"https://orcid.org/0000-0002-2841-6230","observed_orcids":["https://orcid.org/0000-0002-2841-6230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rikio Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040386659","display_name":"Hiroto Ohguchi","orcid":"https://orcid.org/0000-0001-8461-7398","observed_orcids":["https://orcid.org/0000-0001-8461-7398"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroto Ohguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028174720","display_name":"Ola Rizq","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ola Rizq","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Shohei Kikuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shohei Kikuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045867778","display_name":"Yasuhiro Yoshida","orcid":"https://orcid.org/0000-0003-1658-3119","observed_orcids":["https://orcid.org/0000-0003-1658-3119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasuhiro Yoshida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065898212","display_name":"Jana Jakub\u0131\u0301kov\u00e1","orcid":"https://orcid.org/0000-0003-2593-569X","observed_orcids":["https://orcid.org/0000-0003-2593-569X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jana Jakubikova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083655413","display_name":"Diana D. Cirstea","orcid":"https://orcid.org/0000-0002-5719-581X","observed_orcids":["https://orcid.org/0000-0002-5719-581X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Cirstea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049134468","display_name":"G\u00fcll\u00fc G\u00f6rg\u00fcn","orcid":"https://orcid.org/0000-0001-9875-8394","observed_orcids":["https://orcid.org/0000-0001-9875-8394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gullu Gorgun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109387516","display_name":"Jiro Minami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiro Minami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Tzu Tai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077000893","display_name":"Teruhiro Utsugi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teruhiro Utsugi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029593209","display_name":"Atsushi Iwama","orcid":"https://orcid.org/0000-0001-9410-8992","observed_orcids":["https://orcid.org/0000-0001-9410-8992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Atsushi Iwama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/akt-inhibition","display_name":"AKT inhibition","score":0.7300000190734863},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9860000014305115},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.9639999866485596},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/side-population","display_name":"side population cells","score":0.7609999775886536},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.878000020980835},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7839999794960022},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.7360000014305115},{"id":"https://openalex.org/keywords/synergistic-cytotoxicity","display_name":"synergistic cytotoxicity","score":0.6740000247955322},{"id":"https://openalex.org/keywords/combination-index","display_name":"combination index","score":0.5889999866485596}],"concepts":[{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.8409534692764282},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.8128035068511963},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.8021525144577026},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4927652180194855},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.4316721558570862},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43158698081970215},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.428976833820343},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.42553484439849854},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33325207233428955},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3225007653236389},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.28187334537506104},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.278995156288147},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.23925146460533142},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.20169973373413086},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1590304672718048},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11635750532150269}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22403628","doi":"https://doi.org/10.1158/0008-5472.22403628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22403628","pdf_url":"https://aacr.figshare.com/ndownloader/files/39849438","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22403628.v1","doi":"https://doi.org/10.1158/0008-5472.22403628.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22403628.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22403628","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_1_-_10_Tables_1_-_4_from_Selective_and_Potent_Akt_Inhibition_Triggers_Anti-Myeloma_Activities_and_Enhances_Fatal_Endoplasmic_Reticulum_Stress_Induced_by_Proteasome_Inhibition/22403628","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22403628","doi":"https://doi.org/10.1158/0008-5472.22403628","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22403628","pdf_url":"https://aacr.figshare.com/ndownloader/files/39849438","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361811274.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1987974441","https://openalex.org/W4392679638","https://openalex.org/W2560566130","https://openalex.org/W2984182873","https://openalex.org/W2009277768","https://openalex.org/W2228141886","https://openalex.org/W2569154304","https://openalex.org/W2616615380","https://openalex.org/W2289079909","https://openalex.org/W2560424360"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"648K,":[3],"Figure":[4,17,30,39,59,72,82,94,103,117],"S1.":[5,142],"TAS-117":[6,32,41,61,74,84,96,105,119,143,154,165,176],"is":[7],"a":[8],"novel":[9],"potent":[10],"and":[11,24,49,89],"selective":[12],"inhibitor":[13],"of":[14,21,44,87,115,133,138],"Akt":[15,23,25,57,70],"kinases.":[16],"S2.":[18,153],"Basal":[19],"expression":[20],"phosphorylated":[22],"in":[26,52,80,91,100,106,120,127,149,160,171,182],"MM":[27,92,101],"cell":[28],"lines.":[29],"S3.":[31,164],"inhibits":[33],"neither":[34],"MEK/ERK":[35],"nor":[36],"JAK2/STAT":[37],"pathway.":[38],"S4.":[40,175],"modulates":[42],"phenotype":[43],"side":[45],"population":[46],"(SP)":[47],"cells":[48,54,129],"induces":[50,97,124],"cytotoxicity":[51,126],"SP":[53],"associated":[55,135],"with":[56,108,122,130,136,147,158,169,180],"inhibition.":[58],"S5.":[60],"overcomes":[62],"cytoprotective":[63],"effects":[64],"conferred":[65],"by":[66,68],"cytokines":[67],"blocking":[69],"activation.":[71],"S6.":[73],"treatment":[75],"does":[76,110],"not":[77,111],"affect":[78,112],"viability":[79],"BMSCs.":[81],"S7.":[83],"triggers":[85],"cleavage":[86],"caspase":[88],"PARP":[90],"cells.":[93,102,151,162,173,184],"S8.":[95],"autophagosome":[98],"formation":[99],"S9.":[104],"combination":[107,121,144,155,166,177],"bortezomib":[109,148,159],"body":[113],"weight":[114],"mice.":[116],"S10.":[118],"carfilzomib":[123,170,181],"synergistic":[125],"RPMI8226":[128,161,183],"low":[131],"baseline":[132],"p-Akt,":[134],"inhibition":[137],"carfilzomib-induced":[139],"p-Akt.":[140],"Table":[141,152,163,174],"indices":[145,156,167,178],"(CI)":[146,157,168,179],"MM.1S":[150,172]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}